This post contributed by Donald Rosen, MD, chief research officer at the ACR Center for Research and Innovation.
The ACR Center for Research and Innovation (CRI) remains at the vanguard of diagnostic imaging, radiation oncology and imaging science research.
Just this week the NRG-RTOG 9601 study, published in The New England Journal of Medicine, found that those whose prostate cancer returns after surgery are more likely to survive if, along with the usual radiation, they also take drugs to block male hormones.
These research results, covered by most major U.S. news outlets, are a prime example of how the CRI supports the infrastructure of imaging science and the dedication of imaging scientists.
The ACR CRI supports and facilitates scientific researchers who are working toward establishing tomorrow’s standards of care through the discovery of improved diagnostic techniques and treatments for disease and injury. These advances are what keep radiology and radiation oncology at the forefront of medicine and improve the care that we provide to our patients.
The CRI coordinates, operates and participates in diverse imaging science research. In the CRI’s history it has participated in hundreds of trials, registries and data science research projects.
The Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) study, supported by the Alzheimer’s Association, is operated within the ACR CRI. The center also provides operational services for the NCTN and NCORP programs of the NCI through relationships with the ECOG-ACRIN, NRG Oncology and Imaging and Radiation Oncology Core (IROC) grants.
I would be interested in knowing:
- Why do you think clinical research is vital to radiology’s future and to patient care?
- Do you participate in imaging or radiation therapy research? If so, what barriers do you see to increased participation?
- How can ACR research help you develop your scientific research interests?
Please share your thoughts in the comments section below and/or join the discussion on Engage (login required).